1387P Final analysis of the phase Ib/II study of sabizabulin in men with metastatic castration-resistant prostate cancer who progressed on an androgen receptor targeting agent

Autor: M.C. Markowski, M. Eisenberger, C. Pieczonka, D. Rodriguez, K.G. Barnette, R.H. Getzenberg, M.S. Steiner, D.R. Saltzstein, E.S. Antonarakis, R.F. Tutrone
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S1177
ISSN: 0923-7534
Databáze: OpenAIRE